Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.

Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, Hoyo C, Berchuck A, Sandler DP, Taylor JA, O'Brien KM, Velez Edwards DR, Edwards TL, Beeghly-Fadiel A, Wentzensen N, Pearce CL, Wu AH, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Modugno F, Ness R, Moysich K, Rossing MA, Doherty JA, Sellers TA, Permuth-Way JB, Monteiro AN, Levine DA, Setiawan VW, Haiman CA, LeMarchand L, Wilkens LR, Karlan BY, Menon U, Ramus S, Gayther S, Gentry-Maharaj A, Terry KL, Cramer DW, Goode EL, Larson MC, Kaufmann SH, Cannioto R, Odunsi K, Etter JL, Huang RY, Bernardini MQ, Tone AA, May T, Goodman MT, Thompson PJ, Carney ME, Tworoger SS, Poole EM, Lambrechts D, Vergote I, Vanderstichele A, Van Nieuwenhuysen E, Anton-Culver H, Ziogas A, Brenton JD, Bjorge L, Salvensen HB, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Moffitt M, Cook L, Le ND, Brooks-Wilson A, Kelemen LE, Pharoah PDP, Song H, Campbell I, Eccles D, DeFazio A, Kennedy CJ, Schildkraut JM.

Cancer Med. 2019 May;8(5):2503-2513. doi: 10.1002/cam4.1996. Epub 2019 Apr 18.

2.

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, Nelson SC, Sinnott-Armstrong NA, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ, Cuk K, Curtis KR, de la Chapelle A, Doheny KF, Duggan D, Easton DF, Elias SG, Elliott F, English DR, Feskens EJM, Figueiredo JC, Fischer R, FitzGerald LM, Forman D, Gala M, Gallinger S, Gauderman WJ, Giles GG, Gillanders E, Gong J, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Hunter DJ, Ibañez-Sanz G, Idos GE, Ingersoll R, Jackson RD, Jacobs EJ, Jenkins MA, Joshi AD, Joshu CE, Keku TO, Key TJ, Kim HR, Kobayashi E, Kolonel LN, Kooperberg C, Kühn T, Küry S, Kweon SS, Larsson SC, Laurie CA, Le Marchand L, Leal SM, Lee SC, Lejbkowicz F, Lemire M, Li CI, Li L, Lieb W, Lin Y, Lindblom A, Lindor NM, Ling H, Louie TL, Männistö S, Markowitz SD, Martín V, Masala G, McNeil CE, Melas M, Milne RL, Moreno L, Murphy N, Myte R, Naccarati A, Newcomb PA, Offit K, Ogino S, Onland-Moret NC, Pardini B, Parfrey PS, Pearlman R, Perduca V, Pharoah PDP, Pinchev M, Platz EA, Prentice RL, Pugh E, Raskin L, Rennert G, Rennert HS, Riboli E, Rodríguez-Barranco M, Romm J, Sakoda LC, Schafmayer C, Schoen RE, Seminara D, Shah M, Shelford T, Shin MH, Shulman K, Sieri S, Slattery ML, Southey MC, Stadler ZK, Stegmaier C, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Thomas SS, Toland AE, Trichopoulou A, Ulrich CM, Van Den Berg DJ, van Duijnhoven FJB, Van Guelpen B, van Kranen H, Vijai J, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Win AK, Wolf CR, Wolk A, Woods MO, Wu AH, Zaidi SH, Zanke BW, Zhang Q, Zheng W, Scacheri PC, Potter JD, Bassik MC, Kundaje A, Casey G, Moreno V, Abecasis GR, Nickerson DA, Gruber SB, Hsu L, Peters U.

Nat Genet. 2019 Jan;51(1):76-87. doi: 10.1038/s41588-018-0286-6. Epub 2018 Dec 3.

3.

Lifestyle Factors, Colorectal Tumor Methylation, and Survival Among African Americans and European Americans.

Busch EL, Galanko JA, Sandler RS, Goel A, Keku TO.

Sci Rep. 2018 Jun 21;8(1):9470. doi: 10.1038/s41598-018-27738-x.

4.

An Aberrant Microbiota is not Strongly Associated with Incidental Colonic Diverticulosis.

Jones RB, Fodor AA, Peery AF, Tsilimigras MCB, Winglee K, McCoy A, Sioda M, Sandler RS, Keku TO.

Sci Rep. 2018 Mar 21;8(1):4951. doi: 10.1038/s41598-018-23023-z.

5.

Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.

Busch EL, Don PK, Chu H, Richardson DB, Keku TO, Eberhard DA, Avery CL, Sandler RS.

BMC Cancer. 2018 Jan 16;18(1):82. doi: 10.1186/s12885-017-3964-3.

6.

Maternal Gut Microbiome Biodiversity in Pregnancy.

Smid MC, Ricks NM, Panzer A, Mccoy AN, Azcarate-Peril MA, Keku TO, Boggess KA.

Am J Perinatol. 2018 Jan;35(1):24-30. doi: 10.1055/s-0037-1604412. Epub 2017 Jul 27.

7.

Colonic Diverticula Are Not Associated With Mucosal Inflammation or Chronic Gastrointestinal Symptoms.

Peery AF, Keku TO, Addamo C, McCoy AN, Martin CF, Galanko JA, Sandler RS.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):884-891.e1. doi: 10.1016/j.cgh.2017.05.051. Epub 2017 Jun 8.

8.

Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.

Wang H, Schmit SL, Haiman CA, Keku TO, Kato I, Palmer JR, van den Berg D, Wilkens LR, Burnett T, Conti DV, Schumacher FR, Signorello LB, Blot WJ, Zanetti KA, Harris C, Pande M, Berndt SI, Newcomb PA, West DW, Haile R, Stram DO, Figueiredo JC; Hispanic Colorectal Cancer Study, Le Marchand L.

Int J Cancer. 2017 Jun 15;140(12):2728-2733. doi: 10.1002/ijc.30687. Epub 2017 Mar 28.

9.

Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development.

Ren NSX, Ji M, Tokar EJ, Busch EL, Xu X, Lewis D, Li X, Jin A, Zhang Y, Wu WKK, Huang W, Li L, Fargo DC, Keku TO, Sandler RS, Li X.

Curr Biol. 2017 Feb 20;27(4):483-494. doi: 10.1016/j.cub.2016.12.047. Epub 2017 Feb 2.

10.

Distribution and Characteristics of Colonic Diverticula in a United States Screening Population.

Peery AF, Keku TO, Martin CF, Eluri S, Runge T, Galanko JA, Sandler RS.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):980-985.e1. doi: 10.1016/j.cgh.2016.01.020. Epub 2016 Feb 9.

11.

High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome.

Monteagudo-Mera A, Arthur JC, Jobin C, Keku T, Bruno-Barcena JM, Azcarate-Peril MA.

Benef Microbes. 2016;7(2):247-64. doi: 10.3920/BM2015.0114. Epub 2016 Feb 3.

12.

Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African Americans.

Wang H, Iwasaki M, Haiman CA, Kono S, Wilkens LR, Keku TO, Berndt SI, Tsugane S, Le Marchand L.

PLoS One. 2015 Dec 18;10(12):e0144955. doi: 10.1371/journal.pone.0144955. eCollection 2015.

13.

Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease.

Busch EL, Keku TO, Richardson DB, Cohen SM, Eberhard DA, Avery CL, Sandler RS.

Clin Exp Metastasis. 2016 Jan;33(1):53-62. doi: 10.1007/s10585-015-9757-7. Epub 2015 Oct 27.

14.

Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.

Allali I, Delgado S, Marron PI, Astudillo A, Yeh JJ, Ghazal H, Amzazi S, Keku T, Azcarate-Peril MA.

Gut Microbes. 2015;6(3):161-72. doi: 10.1080/19490976.2015.1039223.

15.

The gastrointestinal microbiota and colorectal cancer.

Keku TO, Dulal S, Deveaux A, Jovov B, Han X.

Am J Physiol Gastrointest Liver Physiol. 2015 Mar 1;308(5):G351-63. doi: 10.1152/ajpgi.00360.2012. Epub 2014 Dec 24. Review.

16.

Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.

Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, Pande M, Amos CI, West DW, Bézieau S, Berndt SI, Zanke BW, Hsu L; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Lindor NM, Haile RW, Hopper JL, Jenkins MA, Gallinger S, Casey G; Colon Cancer Family Registry (CCFR), Stenzel SL, Schumacher FR, Peters U, Gruber SB; Colorectal Transdisciplinary Study (CORECT), Tsugane S, Stram DO, Le Marchand L.

Nat Commun. 2014 Aug 8;5:4613. doi: 10.1038/ncomms5613.

17.

Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk.

Santoro MA, Andres SF, Galanko JA, Sandler RS, Keku TO, Lund PK.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2093-100. doi: 10.1158/1055-9965.EPI-14-0177. Epub 2014 Jul 13.

18.

Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.

Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, Smith EJ, Lee M, Janke R, Ngo T, Tejada R, Ji M, Kinseth M, Cabrera BL, Miyai K, Keku TO, Martin CF, Galanko JA, Sandler RS, McGuire KL.

PLoS One. 2014 Jun 23;9(6):e100461. doi: 10.1371/journal.pone.0100461. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103699.

19.

Gut microbiome and colorectal adenomas.

Dulal S, Keku TO.

Cancer J. 2014 May-Jun;20(3):225-31. doi: 10.1097/PPO.0000000000000050. Review.

20.

Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans.

Kupfer SS, Skol AD, Hong E, Ludvik A, Kittles RA, Keku TO, Sandler RS, Ellis NA.

Carcinogenesis. 2014 Sep;35(9):2025-30. doi: 10.1093/carcin/bgu088. Epub 2014 Apr 21.

21.

Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.

Steck SE, Butler LM, Keku T, Antwi S, Galanko J, Sandler RS, Hu JJ.

Mutat Res. 2014 Apr;762:24-31. doi: 10.1016/j.mrfmmm.2014.02.004. Epub 2014 Mar 7.

22.

Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas.

Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO.

J Proteome Res. 2014 Apr 4;13(4):1921-9. doi: 10.1021/pr4009783. Epub 2014 Mar 21.

23.

Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.

Pibiri F, Kittles RA, Sandler RS, Keku TO, Kupfer SS, Xicola RM, Llor X, Ellis NA.

Cancer Causes Control. 2014 May;25(5):561-70. doi: 10.1007/s10552-014-0361-y. Epub 2014 Feb 23.

24.

Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas.

Kang M, Peery AF, Locklear C, Galanko JA, Sandler RS, Keku TO.

J Gastroenterol Hepatol Res. 2013 Apr 14;2(4):531-535.

25.

Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.

Kang M, Shen XJ, Kim S, Araujo-Perez F, Galanko JA, Martin CF, Sandler RS, Keku TO.

Cancer Biomark. 2013;13(5):359-66. doi: 10.3233/CBM-130366.

26.

Fusobacterium spp. and colorectal cancer: cause or consequence?

Keku TO, McCoy AN, Azcarate-Peril AM.

Trends Microbiol. 2013 Oct;21(10):506-8. doi: 10.1016/j.tim.2013.08.004. Epub 2013 Sep 9.

27.

Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans.

Wang H, Haiman CA, Burnett T, Fortini BK, Kolonel LN, Henderson BE, Signorello LB, Blot WJ, Keku TO, Berndt SI, Newcomb PA, Pande M, Amos CI, West DW, Casey G, Sandler RS, Haile R, Stram DO, Le Marchand L.

Hum Mol Genet. 2013 Dec 15;22(24):5048-55. doi: 10.1093/hmg/ddt337. Epub 2013 Jul 12.

28.

Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas.

Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, Keku TO.

BMC Cancer. 2013 Feb 26;13:91. doi: 10.1186/1471-2407-13-91.

29.

Fusobacterium is associated with colorectal adenomas.

McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO.

PLoS One. 2013;8(1):e53653. doi: 10.1371/journal.pone.0053653. Epub 2013 Jan 15.

30.

The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies.

Hodgson ME, Olshan AF, North KE, Poole CL, Zeng D, Tse CK, Keku TO, Galanko J, Sandler R, Millikan RC.

Int J Mol Epidemiol Genet. 2012;3(4):333-60. Epub 2012 Nov 15.

31.

Differences in microbial signatures between rectal mucosal biopsies and rectal swabs.

Araújo-Pérez F, McCoy AN, Okechukwu C, Carroll IM, Smith KM, Jeremiah K, Sandler RS, Asher GN, Keku TO.

Gut Microbes. 2012 Nov-Dec;3(6):530-5. doi: 10.4161/gmic.22157. Epub 2012 Oct 11.

32.

Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa.

Vidal AC, Lund PK, Hoyo C, Galanko J, Burcal L, Holston R, Massa B, Omofoye O, Sandler RS, Keku TO.

BMC Cancer. 2012 Sep 5;12:389. doi: 10.1186/1471-2407-12-389.

33.

Intestinal inflammation targets cancer-inducing activity of the microbiota.

Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C.

Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16.

34.

Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome.

Hoskins JM, Ong PS, Keku TO, Galanko JA, Martin CF, Coleman CA, Wolfe M, Sandler RS, McLeod HL.

PLoS One. 2012;7(7):e41954. doi: 10.1371/journal.pone.0041954. Epub 2012 Jul 27.

35.

Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, Randall TA, Galanko J, Benson A, Sandler RS, Rawls JF, Abdo Z, Fodor AA, Keku TO.

ISME J. 2012 Oct;6(10):1858-68. doi: 10.1038/ismej.2012.43. Epub 2012 May 24.

36.

Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.

Keku TO, Vidal A, Oliver S, Hoyo C, Hall IJ, Omofoye O, McDoom M, Worley K, Galanko J, Sandler RS, Millikan R.

Cancer Causes Control. 2012 Jul;23(7):1127-38. doi: 10.1007/s10552-012-9981-2. Epub 2012 May 8.

37.

Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.

Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, Marchand LL, Hautaniemi S, Askhtorab H, Smoot D, Sandler RS, Keku T, Kupfer SS, Ellis NA, Haiman CA, Taipale J, Aaltonen LA.

Cancer Genet. 2012 Jan-Feb;205(1-2):25-33. doi: 10.1016/j.cancergen.2012.01.005.

38.

IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.

Hoyo C, Murphy SK, Schildkraut JM, Vidal AC, Skaar D, Millikan RC, Galanko J, Sandler RS, Jirtle R, Keku T.

Dis Markers. 2012;32(2):133-41. doi: 10.3233/DMA-2011-0865.

39.

Differential gene expression between African American and European American colorectal cancer patients.

Jovov B, Araujo-Perez F, Sigel CS, Stratford JK, McCoy AN, Yeh JJ, Keku T.

PLoS One. 2012;7(1):e30168. doi: 10.1371/journal.pone.0030168. Epub 2012 Jan 19.

40.

Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians.

Kupfer SS, Anderson JR, Ludvik AE, Hooker S, Skol A, Kittles RA, Keku TO, Sandler RS, Ruiz-Ponte C, Castellvi-Bel S, Castells A, Carracedo A, Ellis NA.

PLoS One. 2011;6(10):e26123. doi: 10.1371/journal.pone.0026123. Epub 2011 Oct 27.

41.

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexø BA, Tjønneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Corredera C, Fuentelsaz V, Grasa P, Navarrete S, Fuertes F, García-Prats MD, Sanambrosio E, Panadero A, De Juan A, Garcia A, Rivera F, Planelles D, Soriano V, Requena C, Aben KK, van Rossum MM, Cremers RG, van Oort IM, van Spronsen DJ, Schalken JA, Peters WH, Helfand BT, Donovan JL, Hamdy FC, Badescu D, Codreanu O, Jinga M, Csiki IE, Constantinescu V, Badea P, Mates IN, Dinu DE, Constantin A, Mates D, Kristjansdottir S, Agnarsson BA, Jonsson E, Barkardottir RB, Einarsson GV, Sigurdsson F, Moller PH, Stefansson T, Valdimarsson T, Johannsson OT, Sigurdsson H, Jonsson T, Jonasson JG, Tryggvadottir L, Rice T, Hansen HM, Xiao Y, Lachance DH, O Neill BP, Kosel ML, Decker PA, Thorleifsson G, Johannsdottir H, Helgadottir HT, Sigurdsson A, Steinthorsdottir V, Lindblom A; Swedish Low-risk Colorectal Cancer Study Group, Sandler RS, Keku TO, Banasik K, Jørgensen T, Witte DR, Hansen T, Pedersen O, Jinga V, Neal DE, Catalona WJ, Wrensch M, Wiencke J, Jenkins RB, Nagore E, Vogel U, Kiemeney LA, Kumar R, Mayordomo JI, Olafsson JH, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K.

Nat Genet. 2011 Sep 25;43(11):1098-103. doi: 10.1038/ng.926.

42.

Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.

Tippin BL, Levine AJ, Materi AM, Song WL, Keku TO, Goodman JE, Sansbury LB, Das S, Dai A, Kwong AM, Lin AM, Lin JM, Park JM, Patterson RE, Chlebowski RT, Garavito RM, Inoue T, Cho W, Lawson JA, Kapoor S, Kolonel LN, Le Marchand L, Haile RW, Sandler RS, Lin HJ.

Prostaglandins Other Lipid Mediat. 2012 Jan;97(1-2):22-8. doi: 10.1016/j.prostaglandins.2011.07.006. Epub 2011 Jul 28.

43.

Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5.

Dellon ES, Bower JJ, Keku TO, Chen X, Miller CR, Woosley JT, Orlando RC, Shaheen NJ.

Dis Esophagus. 2012 Feb;25(2):166-74. doi: 10.1111/j.1442-2050.2011.01230.x. Epub 2011 Aug 5.

44.

Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.

Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y.

Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G799-807. doi: 10.1152/ajpgi.00154.2011. Epub 2011 Jul 7.

45.

Relationship of EMAST and microsatellite instability among patients with rectal cancer.

Devaraj B, Lee A, Cabrera BL, Miyai K, Luo L, Ramamoorthy S, Keku T, Sandler RS, McGuire KL, Carethers JM.

J Gastrointest Surg. 2010 Oct;14(10):1521-8. doi: 10.1007/s11605-010-1340-6. Epub 2010 Sep 16.

46.

Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, Jovov B, Abdo Z, Sandler RS, Keku TO.

Gut Microbes. 2010 May-Jun;1(3):138-47. doi: 10.4161/gmic.1.3.12360. Epub 2010 May 13.

47.

Associations of red meat, fat, and protein intake with distal colorectal cancer risk.

Williams CD, Satia JA, Adair LS, Stevens J, Galanko J, Keku TO, Sandler RS.

Nutr Cancer. 2010;62(6):701-9. doi: 10.1080/01635581003605938.

48.

Genetic heterogeneity in colorectal cancer associations between African and European americans.

Kupfer SS, Anderson JR, Hooker S, Skol A, Kittles RA, Keku TO, Sandler RS, Ellis NA.

Gastroenterology. 2010 Nov;139(5):1677-85, 1685.e1-8. doi: 10.1053/j.gastro.2010.07.038. Epub 2010 Jul 24.

49.

Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.

Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C.

Inflamm Bowel Dis. 2011 Jan;17(1):289-97. doi: 10.1002/ibd.21366.

50.

Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk.

Hamilton KE, Lund PK, Galanko JA, Sandler RS, Keku TO.

BMC Res Notes. 2010 May 25;3:144. doi: 10.1186/1756-0500-3-144.

Supplemental Content

Support Center